Storage and handling
Other information store at 20-25°C (68-77°F). Avoid excessive heat above 40°C (104°F). read all warnings and directions before use. Keep carton.
Other information store at 20-25°C (68-77°F). Avoid excessive heat above 40°C (104°F). read all warnings and directions before use. Keep carton.
Ibuprofen 200 mg (NSAID)*
Phenylephrine HCl 10 mg
*nonsteroidal anti-inflammatory drug
Pain reliever/fever reducer
Nasal decongestant
Uses
Warnings
If an allergic reaction occurs, stop use and seek medical help right away.
Heart attack and stroke warning:NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
If pregnant or breast-feeding,ask a health professional before use. It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
Other information
Inactive ingredients
acesulfame potassium, artificial flavor, carnauba wax, colloidal silicon dioxide, corn starch, croscarmellose sodium, glycerin, hypromellose, lactic acid, lecithin, maltodextrin, medium-chain triglycerides, microcrystalline cellulose, pharmaceutical ink, polydextrose, polyvinyl alcohol, pregelatinized starch, propyl gallate, sodium lauryl sulfate, stearic acid, sucralose, synthetic iron oxide, talc, titanium dioxide, triacetin, xanthan gum
Questions or comments?
Call weekdays from 9 AM to 5 PM ESTtoll free at 1-800-88-ADVIL
READ AND KEEP CARTON FOR COMPLETE
WARNINGS AND INFORMATION
Product inside sealed in plastic blister with foil backing.
Do Not Use if plastic blister or foil barrier is broken.
Distributed by: GSK Consumer Healthcare, Warren, NJ 07059
For most recent product information,
visit
www.advil.com
Trademarks owned or licensed by GSK ©2021 GSK or licensor
| Class | Version | Type | Effective |
|---|---|---|---|
| IBUPROFEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| PHENYLEPHRINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0573-0199-01 | 2024-01-31 | C162847 | 48780-1 | 1030e365-1c23-111a-e063-dadaa90a10e2 | Drug Facts |
| 0573-0199-03 | 2024-01-31 | C162847 | 48780-1 | 1030e365-1c23-111a-e063-dadaa90a10e2 | Drug Facts |
| 0573-0199-11 | 2024-01-31 | C162847 | 48780-1 | 1030e365-1c23-111a-e063-dadaa90a10e2 | Drug Facts |
| 0573-0199-21 | 2024-01-31 | C162847 | 48780-1 | 1030e365-1c23-111a-e063-dadaa90a10e2 | Drug Facts |
| 0573-0199-22 | 2024-01-31 | C162847 | 48780-1 | 1030e365-1c23-111a-e063-dadaa90a10e2 | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0573-0199-01 | ADVIL SINUS CONGESTION AND PAIN | 50 in 1 TRAY | TABLET, COATED | 50 | 15 | |
| 0573-0199-01 | ADVIL SINUS CONGESTION AND PAIN | 1 in 1 POUCH | TABLET, COATED | 1 | 15 | |
| 0573-0199-03 | ADVIL SINUS CONGESTION AND PAIN | 1 in 1 POUCH | TABLET, COATED | 1 | 15 | |
| 0573-0199-03 | ADVIL SINUS CONGESTION AND PAIN | 3000 in 1 CARTON | TABLET, COATED | 3000 | 15 | |
| 0573-0199-11 | ADVIL SINUS CONGESTION AND PAIN | 10 in 1 CARTON | TABLET, COATED | 10 | 15 | |
| 0573-0199-11 | ADVIL SINUS CONGESTION AND PAIN | 1 in 1 BLISTER PACK | TABLET, COATED | 1 | 15 | |
| 0573-0199-21 | ADVIL SINUS CONGESTION AND PAIN | 1 in 1 BLISTER PACK | TABLET, COATED | 1 | 15 | |
| 0573-0199-21 | ADVIL SINUS CONGESTION AND PAIN | 20 in 1 CARTON | TABLET, COATED | 20 | 15 | |
| 0573-0199-22 | ADVIL SINUS CONGESTION AND PAIN | 30 in 1 CARTON | TABLET, COATED | 30 | 15 | |
| 0573-0199-22 | ADVIL SINUS CONGESTION AND PAIN | 1 in 1 BLISTER PACK | TABLET, COATED | 1 | 15 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0573-0199-01 | EA - Each | 0573-0199 | fe6b0032-049b-4318-b7e7-4644ce1a56bb | 1 | 2022-06-06 |
| 0573-0199-11 | EA - Each | 0573-0199 | d09ca4e4-e359-4c8b-8e56-2eb0999773dd | 1 | 2019-06-19 |
| 0573-0199-21 | EA - Each | 0573-0199 | 7c6ed005-4992-481e-9ed0-12a03d86a846 | 1 | 2023-10-16 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| IBUPROFEN | ACTIVE INGREDIENT | WK2XYI10QM | 2 | |
| PHENYLEPHRINE HYDROCHLORIDE | ACTIVE INGREDIENT | 04JA59TNSJ | 2 | |
| IBUPROFEN | ACTIVE MOIETY | WK2XYI10QM | 2 | |
| PHENYLEPHRINE | ACTIVE MOIETY | 1WS297W6MV | 2 | |
| ACESULFAME POTASSIUM | INACTIVE INGREDIENT | 23OV73Q5G9 | 2 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 2 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 2 | |
| EGG PHOSPHOLIPIDS | INACTIVE INGREDIENT | 1Z74184RGV | 2 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 2 | |
| LACTIC ACID | INACTIVE INGREDIENT | 33X04XA5AT | 2 | |
| MALTODEXTRIN | INACTIVE INGREDIENT | 7CVR7L4A2D | 2 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 2 | |
| POLYDEXTROSE | INACTIVE INGREDIENT | VH2XOU12IE | 2 | |
| POLYVINYL ALCOHOL | INACTIVE INGREDIENT | 532B59J990 | 2 | |
| PROPYL GALLATE | INACTIVE INGREDIENT | 8D4SNN7V92 | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 2 | |
| SUCRALOSE | INACTIVE INGREDIENT | 96K6UQ3ZD4 | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 2 | |
| TRIACETIN | INACTIVE INGREDIENT | XHX3C3X673 | 2 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0573-0199 | 0573-0199-11, 0573-0199-21, 0573-0199-01, 0573-0199-22, 0573-0199-03 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER, FOR SUSPENSION / ORAL | 3390 mg/5ml | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, COATED / ORAL | 207.5 mg | ||
| EGG PHOSPHOLIPIDS | EGG PHOSPHOLIPIDS | 1Z74184RGV | TABLET / ORAL | 48 mg | ||
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | SOLUTION / ORAL | 400 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | POWDER, FOR SOLUTION / ORAL | 117 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, COATED / ORAL | 123 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SUSPENSION / ORAL | 10170 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SUSPENSION / ORAL | 10170 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET / ORAL | 45 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, EXTENDED RELEASE / ORAL | 1 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER, FOR SUSPENSION / ORAL | 3390 mg/5ml | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, CHEWABLE / ORAL | 28 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | SUSPENSION / ORAL | 383 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET / ORAL | 56 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TROCHE / ORAL | 948 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | POWDER, FOR SUSPENSION / ORAL | 400 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | FILM / ORAL | 1 mg | ||
| EGG PHOSPHOLIPIDS | EGG PHOSPHOLIPIDS | 1Z74184RGV | TABLET / ORAL | 48 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TROCHE / ORAL | 60 mg | ||
| POLYDEXTROSE | POLYDEXTROSE | VH2XOU12IE | TABLET / ORAL | 20 mg | ||
| PROPYL GALLATE | PROPYL GALLATE | 8D4SNN7V92 | SUSPENSION, EXTENDED RELEASE / ORAL | 4 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | POWDER, FOR SUSPENSION / ORAL | 400 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, COATED / ORAL | 224 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | FILM, SOLUBLE / ORAL | 1 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET / ORAL | 45 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TROCHE / ORAL | 60 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | TABLET, FILM COATED / ORAL | 1.75 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | CAPSULE / ORAL | 4771 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | LOZENGE / ORAL | 115 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | SYRUP / ORAL | 80 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | POWDER, FOR SOLUTION / ORAL | 414 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET / ORAL | 56 mg | ||
| TRIACETIN | TRIACETIN | XHX3C3X673 | TABLET, COATED / ORAL | 1 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | CAPSULE / ORAL | 4771 mg | ||
| POLYDEXTROSE | POLYDEXTROSE | VH2XOU12IE | TABLET / ORAL | 20 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, EXTENDED RELEASE / ORAL | 528 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | SYRUP / ORAL | 80 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | GRANULE / ORAL | 5.4 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, COATED / ORAL | 224 mg | ||
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | TROCHE / ORAL | 26 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 36 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SUSPENSION / ORAL | 600 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, EXTENDED RELEASE / ORAL | 528 mg | ||
| PROPYL GALLATE | PROPYL GALLATE | 8D4SNN7V92 | TABLET, FILM COATED / ORAL | 0.04 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | FILM, SOLUBLE / ORAL | 33 mg | ||
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | TABLET, CHEWABLE / ORAL | 15 mg | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | TABLET, COATED / ORAL | 0.7 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| PROPYL GALLATE | PROPYL GALLATE | 8D4SNN7V92 | CAPSULE / ORAL | 7 mg | ||
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | SOLUTION / ORAL | 400 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 6 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| LACTIC ACID | LACTIC ACID | 33X04XA5AT | CAPSULE / ORAL | 132 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, COATED / ORAL | 5.6 mg | ||
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | POWDER, FOR SUSPENSION / ORAL | 45 mg/5ml |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022565-001 | ADVIL CONGESTION RELIEF | IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N022565-001 | ADVIL CONGESTION RELIEF | 200MG;10MG | TABLET / ORAL | RLD, RS | 2010-05-27 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ADVIL SINUS CONGESTION AND PAIN | IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE | Haleon US Holdings LLC | b1e29c19-fe03-4d2b-b966-0adf4eb4b4cf | 2025-07-22 | Warnings | 0573-0199-01 0573-0199-03 0573-0199-22 0573-0199-21 0573-0199-11 0573-0199 00573019901 00573019921 00573019922 00573019911 00573019903 3a894971-32f7-0c16-e063-6294a90aa8d9 b1e29c19-fe03-4d2b-b966-0adf4eb4b4cf |
Adverse event summaries are temporarily unavailable. Other product information remains available.